<DOC>
	<DOCNO>NCT02851173</DOCNO>
	<brief_summary>This mechanism-driven translational project test efficacy transcranial low-level light/laser therapy ( LLLT ) , enhance cognitive function middle-aged adult .</brief_summary>
	<brief_title>Cognitive Enhancement Through Transcranial Laser Therapy</brief_title>
	<detailed_description>The goal project test efficacy LLLT enhance neurocognitive function middle-aged adult examine modulate influence carotid atherosclerosis . The specific aim accomplish randomize control trial ( RCT ) examine cognitive test performance blood oxygen level-dependent ( BOLD ) response work memory task middle-aged adult pre- post- six-week long intervention LLLT placebo . In addition , investigator examine carotid artery intima-media thickness ( IMT ) moderate therapeutic effect LLLT .</detailed_description>
	<criteria>Men postmenopausal woman , age 4565 neurological disease ( e.g. , large vessel stroke , seizure disorder , Parkinson 's disease , Alzheimer 's disease , clinically significant traumatic brain injury loss consciousness &gt; 30 minute , multiple sclerosis , brain infection/meningitis baseline IQ &lt; 85 placing average range intellectual functioning major psychiatric illness ( e.g. , schizophrenia , bipolar disorder ) substance abuse ( diagnose abuse and/or previous hospitalization substance abuse ) cardiovascular disease , chronic obstructive pulmonary disease , liver kidney disease , inflammatory illness</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>